Septic arthritis due to Salmonella enteritidis associated with infliximab use

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 4, 2005, Pages 304-306

  Katsarolis, Ioannis ^a   Tsiodras, Sotirios ^a   Panagopoulos, Periklis ^a   Giannitsioti, Efthymia ^a   Skarantavos, Grigorios ^a   Ioannidis, Theologos ^a   Giamarellou, Helen ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; C REACTIVE PROTEIN; CIPROFLOXACIN; INFLIXIMAB;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL STRAIN; BACTERIUM CULTURE; CASE REPORT; DEBRIDEMENT; FEMALE; HUMAN; IRON DEFICIENCY ANEMIA; KNEE ARTHROPLASTY; LABORATORY TEST; LEUKOCYTOSIS; RHEUMATOID ARTHRITIS; SALMONELLA ENTERITIDIS; SEROTYPE; STRAIN IDENTIFICATION; SYMPTOMATOLOGY; TREATMENT WITHDRAWAL;

EID: 17444373955     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Maini R, St Clair WE, Breedveld F, Furst D, Kalden J, Weisman M, et al. for the ATTRACT Study Group. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. Lancet 1999;354:1932-9.
2. Day R. Adverse reactions to TNF-α inhibitors in rheumatoid arthritis. Lancet 2002;359:540-1.
3. Krumme B, Conca W, Balle C, Peter HH, Schollmeyer P. Salmonella arthritis in a patient with severe lupus nephritis and thalassaemia minor. Nephron 1995;7:465-7.
4. Miller SI, Pegues DA. Salmonella (including Salmonella typhi). In: Mandell, editor. Principles and Practice of Infectious Disease, 5th edn. Churchill Livingstone Inc; 1995. p. 2345-63.
5. Dinarello CA. Anti-cytokine therapeutics and infections. Vaccine 2003;21(Suppl 2):S24-34.
6. Bresnihan B, Cunnane G. Infection complications associated with the use of biological agents. Rheum Dis Clin North Amer 2003;29:185-202.
7. Netea MG, Radstake T, Joosten LA, van der Meer JW, Barrera P, Kullberg BJ. Salmonella septicaemia in rheumatoid arthritis patients receiving anti-tumour necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression. Arthritis Rheum 2003;48:1853-7.
8. Ang HT, Helfgott S. Do the clinical responses and complications following etanercept or infliximab therapy predict similar outcomes with the other tumour necrosis factor-alpha antagonists in patients with rheumatoid arthritis? J Rheumatol 2003;30:2315-8.